Osaka, Japan

Toshifumi Watanabe


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Kawachinagno, JP (1999)
  • Kawachinagano, JP (1993 - 2000)
  • Osaka, JP (1998 - 2000)

Company Filing History:


Years Active: 1993-2000

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Toshifumi Watanabe

Introduction

Toshifumi Watanabe is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for therapeutic applications. With a total of 7 patents to his name, Watanabe's work has had a considerable impact on medical science.

Latest Patents

Watanabe's latest patents include innovative methods and compositions for prophylactic and therapeutic uses. One notable patent focuses on compounds that exhibit antagonistic activity on endothelin receptors, which can be effectively utilized for the prophylaxis and treatment of organ hypofunction that occurs during surgery or transplantation. Another patent involves thienopyrimidine derivatives, detailing their production and potential applications.

Career Highlights

Watanabe is currently associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to explore various avenues in drug development and contribute to advancements in medical treatments.

Collaborations

Throughout his career, Watanabe has collaborated with notable colleagues, including Mitsuru Shiraishi and Mitsuhiro Wakimasu. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Toshifumi Watanabe's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator in medical science. His work continues to influence therapeutic strategies and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…